Abstract
Women who test positive for a BRCA genetic mutation are at an increased risk for developing hereditary breast and ovarian cancer and have a 50% chance of passing on their genetic mutation to their children. The purpose of this study was to investigate how women who test positive for a BRCA mutation but have not been diagnosed with cancer make decisions regarding family planning. Analysis of interviews with 20 women revealed they engage in logical and emotional decision-making styles. Although women want to be logical to reduce their hereditary cancer risk, emotions often complicate their decision-making. Women experience fear and worry about a future cancer diagnosis, yet also desire to create a family, particularly having children through natural conception. That is, women negotiate having preventative surgeries in a logical doctor-recommended timeframe but also organize those decisions around emotional desires of motherhood. Overall, this study demonstrates the complex decisions women who test positive for a BRCA mutation must make in regards to genetic testing timing, family planning, and overall quality of life.
Similar content being viewed by others
Notes
While this term is commonly used by individuals who test positive for a BRCA genetic mutation, not all BRCA+ individuals identify with this term; however, for the purpose of this study, we use the term as a large majority of our participants identified with it.
According to the National Comprehensive Cancer Network (NCCN) guidelines on genetic/familial high-risk assessment for hereditary breast and ovarian cancer, although there may be some circumstances where healthcare providers may find ovarian screening helpful for patient care, overall data do not support routine ovarian screening.
While the NCCN currently does not recommend women who are carriers of a BRCA mutation undergo a preventative hysterectomy, some women do consider this as a health option.
FORCE originally conceptualized the term previvor in 1999 when one of their members expressed a desire to have a label to identify with.
Intrauterine insemination (IUI) refers to the fertility treatment whereby a sperm is placed directly into a women’s uterus in order to increase the likelihood that many sperm will reach the fallopian tubes and result in a pregnancy.
References
Alwan, S., Yee, I. M., Dybalski, M., Guimond, C., Dwosh, E., Greenwood, T. M., et al. (2012). Reproductive decision making after the diagnosis of multiple sclerosis (MS). Multiple Sclerosis Journal, 19(3), 1–8.
Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J. E., Lynch, P., ... & Thomson, E. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. JAMA, 277(12), 997-1003.
Chan, J. L., Johnson, L. N., Sammel, M. D., DiGiovanni, L., Voong, C., Domchek, S. M., & Gracia, C. R. (2016). Reproductive decision-making in women with BRCA1/2 mutations. Journal of Genetic Counseling, 1–10.
Charles, C., Gafni, A., & Whelan, T. (1999). Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model. Social Science & Medicine, 49(5), 651–661.
Chung, K., Donnez, J., Ginsburg, E., & Meirow, D. (2013). Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. Fertility and Sterility, 99(6), 1534–1542.
Clayman, M. L., Harper, M. M., Quinn, G. P., Reinecke, J., & Shah, S. (2013). Oncofertility resources at NCI-designated comprehensive cancer centers. Journal of the National Comprehensive Cancer Network, 11(12), 1504–1509.
Corbin, J., & Strauss, A. (2007). Basics of qualitative research: techniques and procedures for developing grounded theory (3rd ed.). Thousand Oaks: Sage.
Crockin, S. L. (2005). Legal issues related to parenthood after cancer. Journal of the National Cancer Institute Monographs, 34, 111–113.
d'Agincourt-Canning, L. (2006). Genetic testing for hereditary breast and ovarian cancer: responsibility and choice. Qualitative Health Research, 16(1), 97–118.
de Vries-Kragt, K. (1998). The dilemmas of a carrier of BRCA1 gene mutations. Patient Education and Counseling, 35(1), 75–80.
Dean, M. (2016). “It’s not if I get cancer, it’s when I get cancer”: BRCA-positive patients’(un)certain health experiences regarding hereditary breast and ovarian cancer risk. Social Science & Medicine, 163, 21–27.
Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., et al. (1996). Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33(9), 737–743.
Dimillo, J., Samson, A., Thériault, A., Lowry, S., Corsini, L., Verma, S., et al. (2013). Living with the BRCA genetic mutation: an uncertain conclusion to an unending process. Psychology, Health & Medicine, 18(2), 125–134.
Donnelly, L. S., Watson, M., Moynihan, C., Bancroft, E., Evans, D. G. R., Eeles, R., et al. (2013). Reproductive decision-making in young female carriers of a BRCA mutation. Human Reproduction, 28(4), 1006–1012.
Downing, C. (2005). Negotiating responsibility: case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease. Journal of Genetic Counseling, 14(3), 219–234.
Evans D. G., Gaarenstroom K. N, Stirling D, et al. Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers. Journal of Medical Genetics 2009; 46(9):593–597.
Fisher, C. L. (2010). Coping with breast cancer across adulthood: emotional support communication in the mother–daughter bond. Journal of Applied Communication Research, 38(4), 386–411.
Fisher, C. L., Maloney, E., Glogowski, E., Hurley, K., Edgerson, S., Lichtenthal, W. G., et al. (2014). Talking about familial breast cancer risk topics and strategies to enhance mother–daughter interactions. Qualitative Health Research, 24(4), 517–535.
Forde, O. H. (1998). Is imposing risk awareness cultural imperialism? Social Science & Medicine, 47(9), 1155–1159.
Friedman, L. C., & Kramer, R. M. (2005). Reproductive issues for women with BRCA mutations. Journal of the National Cancer Institute Monographs, 34, 83–86.
Friedman, S., Sutphen, R., & Steligo, K. (2012). Confronting hereditary breast and ovarian cancer: identify your risk, understand your options, change your destiny. New York: John Hopkins University Press.
Geertz, C. (1973). The interpretation of cultures. New York: Basic Books.
Glanz, K., Lewis, F. M., & Rimer, B. K. (2002). Health behavior and health education: theory, research, and practice. San Francisco: Jossey-Bass.
Heritage, J., & Maynard, D. W. (2006). Problems and prospects in the study of physician-patient interaction: 30 years of research. Annual Review of Sociology, 32, 351–374.
Hesse-Biber, S. (2014). The genetic testing experience of BRCA-positive women: deciding between surveillance and surgery. Qualitative Health Research, 24(6), 773–789.
Hesse-Biber, S. N., & Levy, P. (2006). The practice of qualitative research. Thousand Oaks: Sage.
Hoskins, L. M., & Greene, M. H. (2012). Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers. Qualitative Health Research, 22(12), 1633.
Hoskins, L. M., Roy, K., Peters, J. A., Loud, J. T., & Greene, M. H. (2008). Disclosure of positive BRCA1/2-mutation status in young couples: the journey from uncertainty to bonding through partner support. Families, Systems & Health, 26(3), 296–316.
Howard, A. F., Balneaves, L. G., & Bottorff, J. L. (2009). Women’s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review. Journal of Genetic Counseling, 18(6), 578–597.
Howard, A. F., Balneaves, L. G., Bottorff, J. L., & Rodney, P. (2011). Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qualitative Health Research, 21(4), 502–519.
Jolie Pitt, A. (2015). Diary of a surgery. The New York Times. Retrieved from http://www.nytimes.com/2015/03/24/opinion/angelina-jolie-pitt-diary-of-a-surgery.html?_r=0.
Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Decision-making about reproductive choices among individuals at-risk for Huntington's disease. Journal of Genetic Counseling, 16(3), 347–362.
Krahn, T. (2009). Preimplantation genetic diagnosis: does age of onset matter (anymore)? Medicine. Health Care and Philosophy, 12(2), 187–202.
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.
Lindlof, T. R., & Taylor, B. C. (2011). Qualitative communication research methods (3rd ed.). Thousand Oaks, CA: Sage.
Matthews, L. T., Crankshaw, T., Giddy, J., Kaida, A., Smit, J. A., Ware, N. C., & Bangsberg, D. R. (2013). Reproductive decision-making and periconception practices among HIV-positive men and women attending HIV services in Durban, South Africa. AIDS and Behavior, 17(2), 461–470.
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., et al. (2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. Journal of the National Cancer Institute, 105(11), 812–822.
McCullum, M., Bottorff, J. L., Kelly, M., Kieffer, S. A., & Balneaves, L. G. (2007). Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers. BMC Women's Health, 7(1), 1.
Merriam, S. B. (2009). Qualitative research: a guide to design and implementation. San Francisco: Jossey-Bass.
Metcalfe, K., Lynch, H. T., Ghadirian, P., et al. (2004). Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology, 22(12), 2328–2335.
Morgan, M. G., Fischhoff, B., Bostrom, A., & Atman, C. J. (2002). Risk communication: a mental models approach. Cambridge: Cambridge University Press.
Myring, J., Beckett, W., Jassi, R., Roberts, T., Sayers, R., Scotcher, D., & McAllister, M. (2011). Shock, adjust, decide: reproductive decision making in cystic fibrosis (CF) carrier couples—a qualitative study. Journal of Genetic Counseling, 20(4), 404–417.
Neville, K. (1998). The relationships among uncertainty, social support, and psychological distress in adolescents recently diagnosed with cancer. Journal of Pediatric Oncology Nursing, 15, 37–46.
Noble, R., Bahadur, G., Iqbal, M., & Sanyal, A. (2008). Pandora's box: ethics of PGD for inherited risk of late-onset disorders. Reproductive BioMedicine Online, 17, 55–60.
Ormondroyd, E., Donnelly, L., Moynihan, C., Savona, C., Bancroft, E., Evans, D. G., et al. (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. European Journal of Human Genetics, 20(1), 4–10.
Owen, W. F. (1984). Interpretive themes in relational communication. The Quarterly Journal of Speech, 70, 274–287.
Pilarski, R. (2009). Risk perception among women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counseling, 18(4), 303–312.
Politi, M., & Street Jr., R. L. (2011). Patient-centered communication during collaborative decision-making. In T. L. Thompson, R. Parrott, & J. F. Nussbaum (Eds.), The Routledge handbook of health communication (2nd ed., pp. 399–413). New York: Routledge.
Politi, M. C., Han, P. K., & Col, N. F. (2007). Communicating the uncertainty of harms and benefits of medical interventions. Medical Decision Making, 27, 681–695.
Prouix, M., Beaulieu, M. D., Loignon, C., Mayrand, M. H., Maugard, C., Bellavance, N., & Provencher, D. (2009). Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program. Journal of Genetic Counseling, 18(2), 160–172.
Quinn, G. P., Vadaparampil, S. T., Bower, B., Friedman, S., & Keefe, D. L. (2009). Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis. Minerva Medica, 100(5), 371–383.
Quinn, G. P., Vadaparampil, S. T., Jacobsen, P. B., Knapp, C., Keefe, D. L., & Bell, G. E. (2010a). Frozen hope: fertility preservation for women with cancer. Journal of Midwifery and Women’s Health, 55(2), 175–180.
Quinn, G. P., Vadaparampil, S. T., Tollin, S., Miree, C. A., Murphy, D., Bower, B., & Silva, C. (2010b). BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertility and Sterility, 94(6), 2473–2475.
Rauscher, E. A., & Durham, W. T. (2015). “As long as You're sure you Don't want any more children”: Men's collective boundary coordination of information about their affirmative vasectomy decision. Communication Studies, 66(2), 186–203.
Rodney, P., Burgess, M., McPherson, G., & Brown, H. (2004). Our theoretical landscape: a brief history of health care ethics. In J. Storch, P. Rodney, & R. Starzomski (Eds.), Toward a moral horizon: nursing ethics for leadership and practice (pp. 56–97). Toronto: Pearson-Prentice Hall.
Rubin, L. R., Werner-Lin, A., Sagi, M., Cholst, I., Stern, R., Lilienthal, D., & Hurley, K. (2014). ‘the BRCA clock is ticking!’: negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis. Human Fertility, 17(3), 159–164.
Schover, L. R. (2009). Patient attitudes toward fertility preservation. Pediatric Blood & Cancer, 53(2), 281–284.
Smith, K. R., Ellington, L., Chan, A. Y., Croyle, R. T., & Botkin, J. R. (2004). Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiology, Biomarkers and Prevention, 13(5), 733–740.
Staton, A. D., Kurian, A. W., Cobb, K., Mills, M. A., & Ford, J. M. (2008). Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Familial Cancer, 7(2), 179–186.
Stewart, J. L., Lynn, M. R., & Mishel, M. H. (2010). Psychometric evaluation of a new instrument to measure uncertainty in children and adolescents with cancer. Nursing Research, 59, 119–126.
Vadaparampil, S. T., Quinn, G. P., Knapp, C., Malo, T. L., & Friedman, S. (2009). Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer. Genetics in Medicine, 11(10), 757–765.
Vadaparampil, S. T., Scherr, C. L., Cragun, D., Malo, T. L., & Pal, T. (2015). Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida. Clinical Genetics, 87(5), 473–477.
van Manen, M. (1990). Researching lived experience: human science for action sensitive pedagogy. Albany: Suny Press.
Vogel, V. G., Yeomans, A., & Higgibotham, E. (1993). Clinical management of women at increased risk for breast cancer. Breast Cancer Research and Treatment, 28, 195–210.
Wang, C. W., & Hui, E. C. (2009). Ethical, legal and social implications of prenatal and preimplantation genetic testing for cancer susceptibility. Reproductive BioMedicine Online, 19, 23–33.
Weber, K. M., Solomon, D. H., & Meyer, B. J. (2013). A qualitative study of breast cancer treatment decisions: evidence for five decision-making styles. Health Communication, 28(4), 408–421.
Werner-Lin, A. (2007). Danger zones: risk perceptions of young women from families with hereditary breast and ovarian cancer. Family Process, 46(3), 335–349.
Werner-Lin, A. (2008). Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations. Social Work in Health Care, 47(4), 416–437.
Werner-Lin, A., Hoskins, L. M., Doyle, M. H., & Greene, M. H. (2012). ‘Cancer doesn’t have an age’: Genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18–24. Health: An Interdisciplinary Journal for the Social Study of Health, Illness & Medicine, 16(6), 636.
Westin, S. N., Sun, C. C., Lu, K. H., Schmeler, K. M., Soliman, P. T., Lacour, R. A., et al. (2011). Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer, 117(12), 2659–2667.
Woodson, A. H., Muse, K. I., Lin, H., Jackson, M., Mattair, D. N., Schover, L., et al. (2014). Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis. The Oncologist, 19(8), 797–804.
Acknowledgements
We would like to express our gratitude to Facing Our Risk of Cancer Empowered (FORCE) for allowing them to recruit participants. We would also like to thank our participating for being willing to share their family planning experiences with us.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors Marleah Dean, PhD and Emily Rauscher, PhD declare they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Studies
This article does not contain any studies with animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Dean, M., Rauscher, E.A. “It was an Emotional Baby”: Previvors’ Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk. J Genet Counsel 26, 1301–1313 (2017). https://doi.org/10.1007/s10897-017-0069-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-017-0069-8